Imunorregulação central e periférica em pacientes com Síndrome de Down e autoimunidade / Central and peripheral immunoregulation in patients with Down syndrome and autoimmunity

Introdução: A Síndrome de Down (SD) é uma doença genética de alta prevalência, com várias alterações imunológicas decorrentes da disfunção tímica associada à doença. Neste estudo, avaliou-se a associação entre presença de autoimunidade e disfunção do timo em pacientes com SD. Métodos: Foram avaliados 22 pacientes com SD (11 com autoimunidade e 11 sem), que preenchiam os critérios de inclusão: diagnóstico clinico e genético, idade > a 10 anos e sem uso de drogas imunossupressoras. Estes pacientes foram comparados a um grupo controle formado por adolescentes saudáveis (n=11) e outro de pacientes com doenças autoimunes, caracterizados por manifestações clínicas e presença de autoanticorpos (n=11). Todos os grupos foram pareados por idade e sexo. Os parâmetros laboratoriais avaliados foram: número de leucócitos, linfócitos CD3+, CD4+, CD8+, CD19+, CD21+, CD4+CD28null , células T reguladoras (CD4+CD25+Foxp3+), linfócitos T naive (CD4+CD45RA+CD62L+) e linfócitos T de memória (CD4+CD45RO+CD62L- ) e célula NK (CD3-CD16+, CD56+) por citometria de fluxo, Foi também avaliada a concentração de sjTREC (T receptor excision circles) em sangue total por qRT-PCR .Resultados: Nos pacientes com SD, observou-se redução das concentrações séricas de sjTREC, do número de linfócitos B e aumento do número de células CD4+CD28null. Na análise concomitante entre os grupos formados (SD com e sem autoimunidade, controle e autoimunidade sem SD), após correção de Bonferroni, observou-se que o grupo SD com autoimunidade apresentou redução de linfócitos T CD4, linfócitos naive e linfócitos B. Quando comparados os grupos SD com e sem autoimunidade observou-se redução significativa das concentrações de TREC no primeiro grupo. Não houve alterações das Células NK. Em valores percentuais, os pacientes com SD e autoimunidade apresentaram elevação da subpopulação de células T reguladoras. Conclusões: Este estudo mostra que pacientes com SD apresentam disfunção tímica quando avaliados pela...

Introduction: Down syndrome (DS) is a genetic disease of high prevalence, with many immunological alterations as a consequence of thymic disfunction associated to this disease. In this study, it was evaluated the association between the presence of thymic disfunction and autoimmunity in patients with DS. Methods: It was evaluated 22 patients with DS (11 with and 11 without autoimmunity) who fulfilled the inclusion criteria: clinical and genetic diagnosis, and age >10 years and no use of immunosuppressive drugs. These patients were compared to a control group composed by health adolescents (n=11) and patients with autoimmune diseases, characterized by clinical manifestations and autoantibodies (n=11). All groups were matched for age and sex. The laboratory parameters evaluated were: number of leukocytes, CD3+, CD4+, CD8+, CD19+, CD4+CD28null lymphocytes, regulatory T cells (CD4+CD25+Foxp3+), naive T lymphocytes (CD4+CD45RA+CD62L+), memory T lymphocytes (CD4+CD45RO+CD62L-) and NK cells (CD3-CD16+CD56+). The subpopulations of lymphocytes were determined by flow cytometry. It was also evaluated whole blood sjTREC (T receptor excision circles) concentrations by PCR. Results: In DS patients, there was reduction of sjTREC concentration, B lymphocytes number and increase of CD4+CD28null cells number. When compared all the groups formed (SD with and without autoimmunity, autoimmunity without SD and control group), after Bonferroni correction, the SD group with autoimmunity showed a reduction of T CD4+lymphocytes, naïve cells and B lymphocytes. When SD with and without autoimmunity groups were compared it was observed significant reduction in the TREC concentrations in the first group. There were no changes in NK cells. Patients with DS and autoimmune diseases had huge percentages of T reg cells comparing different groups. Conclusions: This study showed that DS patients presented thymic disfunction by reduced levels of whole blood sjTREC, and this condition is...

Identification of clonally rearranged T-cell receptor beta chain genes in HTLV-I carriers as a potential instrument for early detection of neoplasia

We analyzed the genetic recombination pattern of the T-cell receptor beta-chain gene (TCR-beta) in order to identify clonal expansion of T-lymphocytes in 17 human T-lymphotropic virus type I (HTLV-I)-positive healthy carriers, 7 of them with abnormal features in the peripheral blood lymphocytes. Monoclonal or oligoclonal expansion of T-cells was detected in 5 of 7 HTLV-I-positive patients with abnormal lymphocytes and unconfirmed diagnosis by using PCR amplification of segments of TCR-beta gene, in a set of reactions that target 102 different variable (V) segments, covering all members of the 24 V families available in the gene bank, including the more recently identified segments of the Vbeta-5 and Vbeta-8 family and the two diversity beta segments. Southern blots, the gold standard method to detect T-lymphocyte clonality, were negative for all of these 7 patients, what highlights the low sensitivity of this method that requires a large amount of very high quality DNA. To evaluate the performance of PCR in the detection of clonality we also analyzed 18 leukemia patients, all of whom tested positive. Clonal expansion was not detected in any of the negative controls or healthy carriers without abnormal lymphocytes. In conclusion, PCR amplification of segments of rearranged TCR-beta is reliable and highly suitable for the detection of small populations of clonal T-cells in asymptomatic HTLV-I carriers who present abnormal peripheral blood lymphocytes providing an additional instrument for following up these patients with potentially higher risk of leukemia.

High frequency of specific T cell receptor rearrangements in rheumatoid arthritis: analysis of synovial fluid T lymphocytes

1. We have searched for rearrangements in the beta chain T cell receptor genes to identify clonal T lymphocyte populations in the synovial fluid of 10 patients with well established rheumatoid arthritis, using a T cell population unbiased by preselection. 2. Analysis of the restriction fragments with the beta chain constant region probe C beta 2 disclosed a rearranged band in 50 of cases (5/10). No significant differences in age, duration of the disease, treatment employed and presence of articular deformities or erosion upon X-ray examination were observed when patients with or without rearrangements were compared. 3. The rearranged band observed after BamH I digestion was of the same size in the 5 patients (14 kb). In addition, two patients presented a 10-kb rearranged band upon restriction with Hind III. 3. These data indicate that a significant number of rheumatoid arthritis patients probably present oligoclonal T cell proliferation of their synovial fluid lymphocytes.